002437 誉衡药业
交易中 02-09 10:22:30
资讯
新帖
简况
誉衡药业:截至2026年1月30日,公司股东人数为10.30万户
证券之星 · 02-03
誉衡药业:截至2026年1月30日,公司股东人数为10.30万户
誉衡药业(002437)1月20日股东户数9.73万户,较上期减少0.82%
证券之星 · 01-23
誉衡药业(002437)1月20日股东户数9.73万户,较上期减少0.82%
誉衡药业:截至2026年1月20日股东人数为9.73万户
证券之星 · 01-22
誉衡药业:截至2026年1月20日股东人数为9.73万户
异动快报:誉衡药业(002437)1月21日9点31分触及涨停板
证券之星 · 01-21
异动快报:誉衡药业(002437)1月21日9点31分触及涨停板
股市必读:誉衡药业(002437)预计2025年全年归属净利润盈利3.5亿元至4.2亿元
证券之星 · 01-21
股市必读:誉衡药业(002437)预计2025年全年归属净利润盈利3.5亿元至4.2亿元
誉衡药业(002437.SZ)发预增,预计2025年度归母净利润3.5亿元至4.2亿元,增长50.37%至80.44%
智通财经 · 01-20
誉衡药业(002437.SZ)发预增,预计2025年度归母净利润3.5亿元至4.2亿元,增长50.37%至80.44%
誉衡药业(002437)披露董事、高级管理人员通过司法拍卖方式增持的公司股份完成过户,1月19日股价上涨0.94%
证券之星 · 01-19
誉衡药业(002437)披露董事、高级管理人员通过司法拍卖方式增持的公司股份完成过户,1月19日股价上涨0.94%
誉衡药业(002437)公司公告选举徐宇虹为第七届董事会独立董事,1月14日股价上涨0.93%
证券之星 · 01-14
誉衡药业(002437)公司公告选举徐宇虹为第七届董事会独立董事,1月14日股价上涨0.93%
股市必读:誉衡药业(002437)1月13日董秘有最新回复
证券之星 · 01-14
股市必读:誉衡药业(002437)1月13日董秘有最新回复
誉衡药业:华夏时报文章的数据有误
证券之星 · 01-13
誉衡药业:华夏时报文章的数据有误
股市必读:誉衡药业(002437)1月9日董秘有最新回复
证券之星 · 01-12
股市必读:誉衡药业(002437)1月9日董秘有最新回复
誉衡药业:相关股份尚未完成过户
证券之星 · 01-09
誉衡药业:相关股份尚未完成过户
股市必读:誉衡药业(002437)1月6日董秘有最新回复
证券之星 · 01-07
股市必读:誉衡药业(002437)1月6日董秘有最新回复
每周股票复盘:誉衡药业(002437)拟回购注销216万股限制性股票
证券之星 · 01-03
每周股票复盘:誉衡药业(002437)拟回购注销216万股限制性股票
哈尔滨誉衡药业拟回购注销216万股限制性股票
中金财经 · 2025-12-31
哈尔滨誉衡药业拟回购注销216万股限制性股票
誉衡药业:2026年1月14日召开2026年第一次临时股东大会
证券日报 · 2025-12-29
誉衡药业:2026年1月14日召开2026年第一次临时股东大会
誉衡药业:截至2025年12月19日股东人数为10.12万户
证券之星 · 2025-12-23
誉衡药业:截至2025年12月19日股东人数为10.12万户
誉衡药业:相关股份尚未完成过户
证券之星 · 2025-12-17
誉衡药业:相关股份尚未完成过户
誉衡药业(002437)12月10日股东户数10.29万户,较上期减少1.25%
证券之星 · 2025-12-15
誉衡药业(002437)12月10日股东户数10.29万户,较上期减少1.25%
誉衡药业:截至2025年11月28日股东人数为10.42万户
证券之星 · 2025-12-01
誉衡药业:截至2025年11月28日股东人数为10.42万户
加载更多
公司概况
公司名称:
哈尔滨誉衡药业股份有限公司
所属行业:
医药制造业
上市日期:
2010-06-23
主营业务:
哈尔滨誉衡药业股份有限公司的主营业务是药品的研发、生产和销售。公司的主要产品是鹿瓜多肽注射液、安脑丸、安脑片、氯化钾缓释片、注射用磷酸肌酸钠、银杏达莫注射液、注射用多种维生素(12)、注射用氟尿嘧啶、注射用盐酸平阳霉素。公司核心产品市场认可度高,鹿瓜多肽注射液曾被黑龙江省医药行业协会评为“医药行业科技进步奖一等奖”、氯化钾缓释片曾被评为广东省名优高新技术产品、银杏达莫注射液曾被评为山西省名牌产品。
发行价格:
50.00
{"stockData":{"symbol":"002437","market":"SZ","secType":"STK","nameCN":"誉衡药业","latestPrice":3.47,"timestamp":1770603750000,"preClose":3.46,"halted":0,"volume":25614929,"delay":0,"changeRate":0.0029,"floatShares":2098999999,"shares":2232000000,"eps":0.1313,"marketStatus":"交易中","change":0.01,"latestTime":"02-09 10:22:30","open":3.46,"high":3.49,"low":3.45,"amount":88777500,"amplitude":0.0116,"askPrice":3.48,"askSize":20042,"bidPrice":3.47,"bidSize":4212,"shortable":0,"etf":0,"ttmEps":0.1313,"tradingStatus":2,"nextMarketStatus":{"tag":"午间休市","tradingStatus":4,"beginTime":1770607800000},"marketStatusCode":2,"adr":0,"adjPreClose":3.46,"symbolType":"stock","openAndCloseTimeList":[[1770600600000,1770607800000],[1770613200000,1770620400000]],"highLimit":3.81,"lowLimit":3.11,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":2232028126,"isCdr":false,"pbRate":3.58,"roa":"--","peRate":26.428027,"roe":"11.93%","epsLYR":0.1059,"committee":-0.092659,"marketValue":7745000000,"turnoverRate":0.0122,"status":0,"floatMarketCap":7284000000},"requestUrl":"/m/hq/s/002437","defaultTab":"news","newsList":[{"id":"2608933843","title":"誉衡药业:截至2026年1月30日,公司股东人数为10.30万户","url":"https://stock-news.laohu8.com/highlight/detail?id=2608933843","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2608933843?lang=zh_cn&edition=full","pubTime":"2026-02-03 11:33","pubTimestamp":1770089586,"startTime":"0","endTime":"0","summary":"证券之星消息,誉衡药业(002437)02月02日在投资者关系平台上答复投资者关心的问题。投资者提问:请问截止1月31日公司股东人数是多少?谢谢!誉衡药业回复:您好,截至2026年1月30日,公司股东人数为10.30万户。感谢关注!以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026020300016021.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0028","002437","BK0077","BK0060","BK0188","BK0095"],"gpt_icon":0},{"id":"2605751584","title":"誉衡药业(002437)1月20日股东户数9.73万户,较上期减少0.82%","url":"https://stock-news.laohu8.com/highlight/detail?id=2605751584","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2605751584?lang=zh_cn&edition=full","pubTime":"2026-01-23 17:41","pubTimestamp":1769161264,"startTime":"0","endTime":"0","summary":"证券之星消息,近日誉衡药业披露,截至2026年1月20日公司股东户数为9.73万户,较1月9日减少800.0户,减幅为0.82%。在化学制药行业个股中,誉衡药业股东户数高于行业平均水平,截至1月20日,化学制药行业平均股东户数为3.43万户。从股价来看,2026年1月9日至2026年1月20日,誉衡药业区间跌幅为0.31%,在此期间股东户数减少800.0户,减幅为0.82%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026012300029385.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002437","BK0060","BK0077","BK0188","BK0239","BK0028","BK0095"],"gpt_icon":0},{"id":"2605377134","title":"誉衡药业:截至2026年1月20日股东人数为9.73万户","url":"https://stock-news.laohu8.com/highlight/detail?id=2605377134","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2605377134?lang=zh_cn&edition=full","pubTime":"2026-01-22 09:12","pubTimestamp":1769044329,"startTime":"0","endTime":"0","summary":"证券之星消息,誉衡药业(002437)01月21日在投资者关系平台上答复投资者关心的问题。投资者提问:尊敬的董秘,您好!敬请发布截至1月20日公司股东户数信息。谢谢!致礼!誉衡药业回复:您好,截至2026年1月20日,公司股东人数为9.73万户。感谢关注!以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026012200006721.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0060","BK0188","BK0077","BK0028","BK0095","002437","BK0239"],"gpt_icon":0},{"id":"2605263511","title":"异动快报:誉衡药业(002437)1月21日9点31分触及涨停板","url":"https://stock-news.laohu8.com/highlight/detail?id=2605263511","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2605263511?lang=zh_cn&edition=full","pubTime":"2026-01-21 09:36","pubTimestamp":1768959408,"startTime":"0","endTime":"0","summary":"证券之星1月21日盘中消息,9点31分誉衡药业(002437)触及涨停板。其所属行业化学制药目前下跌。领涨股为汉商集团。该股为PD-1抑制剂,中药,维生素概念热股。1月20日的资金流向数据方面,主力资金净流出2359.23万元,占总成交额19.36%,游资资金净流入900.23万元,占总成交额7.39%,散户资金净流入1458.99万元,占总成交额11.97%。近5日资金流向一览见下表:誉衡药业主要指标及行业内排名如下:以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026012100007893.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002437","BK0060","BK0239","BK0077","BK0028","BK0188","BK0095"],"gpt_icon":0},{"id":"2605148634","title":"股市必读:誉衡药业(002437)预计2025年全年归属净利润盈利3.5亿元至4.2亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2605148634","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2605148634?lang=zh_cn&edition=full","pubTime":"2026-01-21 01:28","pubTimestamp":1768930090,"startTime":"0","endTime":"0","summary":"业绩披露要点业绩预告誉衡药业发布业绩预告,预计2025年全年归属净利润盈利3.5亿元至4.2亿元,同比增长50.37%至80.44%;预计每股收益盈利0.1597元至0.1917元;扣非后净利润预计盈利1.85亿元至2.2亿元,同比增长0.92%至20.02%。2025年度业绩预增公告哈尔滨誉衡药业股份有限公司预计2025年度归属于上市公司股东的净利润为35,000.00万元至42,000.00万元,同比增长50.37%至80.44%;扣除非经常性损益后的净利润为18,500.00万元至22,000.00万元,同比增长0.92%至20.02%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026012100000664.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002437"],"gpt_icon":0},{"id":"2604965081","title":"誉衡药业(002437.SZ)发预增,预计2025年度归母净利润3.5亿元至4.2亿元,增长50.37%至80.44%","url":"https://stock-news.laohu8.com/highlight/detail?id=2604965081","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2604965081?lang=zh_cn&edition=full","pubTime":"2026-01-20 17:26","pubTimestamp":1768901202,"startTime":"0","endTime":"0","summary":"智通财经APP讯,誉衡药业(002437.SZ)披露2025年度业绩预增公告,公司预计归属于上市公司股东的净利润3.5亿元至4.2亿元,同比增长50.37%至80.44%;扣除非经常性损益后的净利润1.85亿元至2.2亿元,同比增长0.92%至20.02%。报告期,公司部分核心产品如注射用多种维生素(12)、氯化钾缓释片、安脑丸/片、鹿瓜多肽注射液(松梅乐)等产品的销量实现了大幅/稳健增长。此外,西格列汀二甲双胍缓释片、氟比洛芬酯注射液、注射用盐酸罂粟碱等产品贡献增量。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1395098.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":"誉衡药业(002437.SZ)发预增,预计2025年度归母净利润3.5亿元至4.2亿元,增长50.37%至80.44%","news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["002437"],"gpt_icon":0},{"id":"2604913176","title":"誉衡药业(002437)披露董事、高级管理人员通过司法拍卖方式增持的公司股份完成过户,1月19日股价上涨0.94%","url":"https://stock-news.laohu8.com/highlight/detail?id=2604913176","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2604913176?lang=zh_cn&edition=full","pubTime":"2026-01-19 22:54","pubTimestamp":1768834453,"startTime":"0","endTime":"0","summary":"截至2026年1月19日收盘,誉衡药业报收于3.21元,较前一交易日上涨0.94%,最新总市值为71.65亿元。近日,誉衡药业发布公告称,2025年11月21日,公司董事、总经理国磊峰及其一致行动人西藏誉磐通过司法拍卖方式合计竞得公司2,500万股股份,占总股本的1.12%。截至公告日,相关股份已完成过户登记。国磊峰与西藏誉磐合计持有公司4,698万股,占总股本的2.10%。过户完成后六个月内,国磊峰及其一致行动人不得减持所持股份。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026011900036140.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0188","002437","BK0095","BK0077","BK0028","BK0060","BK0239"],"gpt_icon":0},{"id":"2603612229","title":"誉衡药业(002437)公司公告选举徐宇虹为第七届董事会独立董事,1月14日股价上涨0.93%","url":"https://stock-news.laohu8.com/highlight/detail?id=2603612229","media":"证券之星","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2603612229?lang=zh_cn&edition=full","pubTime":"2026-01-14 22:45","pubTimestamp":1768401913,"startTime":"0","endTime":"0","summary":"截至2026年1月14日收盘,誉衡药业报收于3.27元,较前一交易日上涨0.93%,最新总市值为72.99亿元。该股当日开盘3.25元,最高3.31元,最低3.22元,成交额达2.76亿元,换手率为4.03%。近日,哈尔滨誉衡药业股份有限公司召开2026年第一次临时股东会,会议审议通过《关于选举徐宇虹为第七届董事会独立董事的议案》。公告显示,本次会议以网络投票方式举行,共717名股东参与,代表股份328,371,708股,占公司有表决权股份总数的14.7118%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026011400041658.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0188","BK0095","002437","BK0028","BK0060","BK0077","BK0239"],"gpt_icon":0},{"id":"2603369632","title":"股市必读:誉衡药业(002437)1月13日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2603369632","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2603369632?lang=zh_cn&edition=full","pubTime":"2026-01-14 02:48","pubTimestamp":1768330090,"startTime":"0","endTime":"0","summary":"截至2026年1月13日收盘,誉衡药业报收于3.24元,上涨0.93%,换手率4.3%,成交量90.19万手,成交额2.94亿元。董秘最新回复投资者: 请问截至2026年1月10日,公司股东数是多少?董秘: 您好,截至2026年1月9日,公司股东人数为9.81万户。董秘: 您好,若涉及需要发布年度业绩预告的情形,公司将会在2026年1月31日前发布业绩预告。当日关注点来自交易信息汇总:1月13日主力资金净流入958.48万元,显示主力对誉衡药业股票的积极介入。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026011400001360.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0060","BK0188","BK0077","BK0028","BK0095","002437","BK0239"],"gpt_icon":0},{"id":"2603509460","title":"誉衡药业:华夏时报文章的数据有误","url":"https://stock-news.laohu8.com/highlight/detail?id=2603509460","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2603509460?lang=zh_cn&edition=full","pubTime":"2026-01-13 16:31","pubTimestamp":1768293076,"startTime":"0","endTime":"0","summary":"证券之星消息,誉衡药业(002437)01月13日在投资者关系平台上答复投资者关心的问题。投资者提问:去年11月7日,华夏时报公众号(国企)发表“誉衡药业三季报利润飘红背后:理财投资狂赚3.77 亿元 “输血”,营收下滑困局仍难破解”文章,其中写到:前三季度利润的爆发式增长,核心驱动力是委托理财业务的集中发力……累计实现理财收益3.77亿元。请问董秘,以上数据是否有误?誉衡药业回复:您好,华夏时报文章的数据有误,请以公司公告为准。感谢关注!以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026011300025149.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002437","BK0060","BK0028","BK0095","BK0239","BK0077","BK0188"],"gpt_icon":0},{"id":"2602527755","title":"股市必读:誉衡药业(002437)1月9日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2602527755","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2602527755?lang=zh_cn&edition=full","pubTime":"2026-01-12 01:56","pubTimestamp":1768154170,"startTime":"0","endTime":"0","summary":"截至2026年1月9日收盘,誉衡药业报收于3.2元,上涨0.63%,换手率2.57%,成交量53.96万手,成交额1.72亿元。董秘最新回复投资者: 公司12月21号和24号拍卖的股权,茅媛和国磊峰是否已经缴费过户?交易信息汇总资金流向1月9日主力资金净流出1104.35万元;游资资金净流入610.36万元;散户资金净流入493.99万元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026011200000823.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002437","BK0028","BK0095","BK0239","BK0060","BK0188","BK0077"],"gpt_icon":0},{"id":"2602345640","title":"誉衡药业:相关股份尚未完成过户","url":"https://stock-news.laohu8.com/highlight/detail?id=2602345640","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2602345640?lang=zh_cn&edition=full","pubTime":"2026-01-09 11:33","pubTimestamp":1767929630,"startTime":"0","endTime":"0","summary":"证券之星消息,誉衡药业(002437)01月09日在投资者关系平台上答复投资者关心的问题。投资者提问:公司12月21号和24号拍卖的股权,茅媛和国磊峰是否已经缴费过户?誉衡药业回复:您好,相关股份尚未完成过户,感谢关注!以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026010900015070.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0060","BK0188","BK0095","002437","BK0077","BK0028"],"gpt_icon":0},{"id":"2601817119","title":"股市必读:誉衡药业(002437)1月6日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2601817119","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2601817119?lang=zh_cn&edition=full","pubTime":"2026-01-07 03:05","pubTimestamp":1767726314,"startTime":"0","endTime":"0","summary":"截至2026年1月6日收盘,誉衡药业报收于3.18元,上涨0.32%,换手率2.04%,成交量42.74万手,成交额1.36亿元。董秘最新回复投资者: 请问截止12月31日公司股东人数是多少?2025年12月底公司股东总数请您关注公司2025年年度报告,谢谢!当日关注点来自交易信息汇总:1月6日主力资金净流入549.2万元,显示主力对誉衡药业股票的积极介入。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026010700001363.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0188","002437","BK0095","BK0077","BK0028","BK0060","BK0239"],"gpt_icon":0},{"id":"2600609260","title":"每周股票复盘:誉衡药业(002437)拟回购注销216万股限制性股票","url":"https://stock-news.laohu8.com/highlight/detail?id=2600609260","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2600609260?lang=zh_cn&edition=full","pubTime":"2026-01-03 03:47","pubTimestamp":1767383229,"startTime":"0","endTime":"0","summary":"截至2025年12月31日收盘,誉衡药业报收于3.07元,较上周的3.11元下跌1.29%。本周,誉衡药业12月29日盘中最高价报3.12元。本周关注点公司公告汇总:誉衡药业拟回购注销3名离职人员合计216万股限制性股票。本次回购注销符合相关规定,未损害公司及股东利益。会议将审议修订《公司章程》、选举徐宇虹为独立董事、回购注销离职人员限制性股票三项议案。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026010300002348.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0095","BK0060","BK0239","002437","BK0028","BK0077","BK0188"],"gpt_icon":0},{"id":"2595774510","title":"哈尔滨誉衡药业拟回购注销216万股限制性股票","url":"https://stock-news.laohu8.com/highlight/detail?id=2595774510","media":"中金财经","labels":["shareholding","buyback"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2595774510?lang=zh_cn&edition=full","pubTime":"2025-12-31 08:05","pubTimestamp":1767139521,"startTime":"0","endTime":"0","summary":"中访网数据 哈尔滨誉衡药业股份有限公司于2025年12月29日召开董事会,审议通过了回购注销部分限制性股票的议案。核心决策为,因2024年限制性股票激励计划中3名预留授予的激励对象已离职,不符合激励条件,公司决定回购其已获授但尚未解除限售的全部限制性股票,合计2,160,000股,约占公司当前总股本的0.0968%。此次回购注销完成后,公司总股本将由2,232,028,126股减少至2,229,868,126股。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/ggzixun/20251231/31906323.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,buyback","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["002437","BK0060","BK0239","BK0077","BK0028","BK0188","BK0095"],"gpt_icon":0},{"id":"2595673548","title":"誉衡药业:2026年1月14日召开2026年第一次临时股东大会","url":"https://stock-news.laohu8.com/highlight/detail?id=2595673548","media":"证券日报 ","labels":["conferences"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2595673548?lang=zh_cn&edition=full","pubTime":"2025-12-29 22:09","pubTimestamp":1767017340,"startTime":"0","endTime":"0","summary":"证券日报网讯 12月29日,誉衡药业发布公告称,公司将于2026年1月14日15:00召开2026年第一次临时股东大会,审议修订《公司章程》、选举独立董事及回购注销限制性股票等3项议案,网络投票同日9:15-15:00开放。(文章来源:证券日报)\n\n\n海量资讯、精准解读,尽在新浪财经APP","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/relnews/cn/2025-12-29/doc-inhenrqi0057814.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/relnews/cn/2025-12-29/doc-inhenrqi0057814.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK0239","BK0060","BK0188","BK0095","002437","BK0077","BK0028"],"gpt_icon":0},{"id":"2593463610","title":"誉衡药业:截至2025年12月19日股东人数为10.12万户","url":"https://stock-news.laohu8.com/highlight/detail?id=2593463610","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2593463610?lang=zh_cn&edition=full","pubTime":"2025-12-23 11:37","pubTimestamp":1766461025,"startTime":"0","endTime":"0","summary":"证券之星消息,誉衡药业(002437)12月22日在投资者关系平台上答复投资者关心的问题。投资者提问:董秘,您好!请问公司截至12月20日公司的股东人数是多少?谢谢誉衡药业回复:您好!截至2025年12月19日,公司股东人数为10.12万户。感谢关注!以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025122300014810.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0095","002437","BK0028","BK0060","BK0188","BK0077"],"gpt_icon":0},{"id":"2592519239","title":"誉衡药业:相关股份尚未完成过户","url":"https://stock-news.laohu8.com/highlight/detail?id=2592519239","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2592519239?lang=zh_cn&edition=full","pubTime":"2025-12-17 09:12","pubTimestamp":1765933930,"startTime":"0","endTime":"0","summary":"证券之星消息,誉衡药业12月16日在投资者关系平台上答复投资者关心的问题。谢谢誉衡药业回复:您好,根据四川省成都市中级人民法院的公告,竞拍者应于2025年12月6日前将尾款缴纳至法院指定账户,并在2025年12月13日前到法院签署成交确认书等,具体请您参考此前的竞买公告,相关股份尚未完成过户,感谢关注!","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025121700004952.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002437","BK0239","BK0077","BK0095","BK0060","BK0028","BK0188"],"gpt_icon":0},{"id":"2591861218","title":"誉衡药业(002437)12月10日股东户数10.29万户,较上期减少1.25%","url":"https://stock-news.laohu8.com/highlight/detail?id=2591861218","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2591861218?lang=zh_cn&edition=full","pubTime":"2025-12-15 17:45","pubTimestamp":1765791930,"startTime":"0","endTime":"0","summary":"证券之星消息,近日誉衡药业披露,截至2025年12月10日公司股东户数为10.29万户,较11月28日减少1300.0户,减幅为1.25%。在化学制药行业个股中,誉衡药业股东户数高于行业平均水平,截至12月10日,化学制药行业平均股东户数为3.49万户。从股价来看,2025年11月28日至2025年12月10日,誉衡药业区间跌幅为1.55%,在此期间股东户数减少1300.0户,减幅为1.25%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025121500022336.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","BK0060","BK0077","BK0095","BK0188","002437","BK0239"],"gpt_icon":0},{"id":"2588728511","title":"誉衡药业:截至2025年11月28日股东人数为10.42万户","url":"https://stock-news.laohu8.com/highlight/detail?id=2588728511","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2588728511?lang=zh_cn&edition=full","pubTime":"2025-12-01 16:54","pubTimestamp":1764579276,"startTime":"0","endTime":"0","summary":"证券之星消息,誉衡药业(002437)12月01日在投资者关系平台上答复投资者关心的问题。投资者提问:请问公司截至11月30日的股东人数是多少,谢谢誉衡药业回复:您好!截至2025年11月28日,公司股东人数为10.42万户。感谢关注!以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025120100019994.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0077","BK0188","002437","BK0028","BK0239","BK0060","BK0095"],"gpt_icon":0}],"profile":{"ret":0,"serverTime":1770603753040,"stockEarnings":[{"period":"1week","weight":0.0147},{"period":"1month","weight":0.1019},{"period":"3month","weight":0.0298},{"period":"6month","weight":-0.0254},{"period":"1year","weight":0.3676},{"period":"ytd","weight":0.127}],"compareEarnings":[{"period":"1week","weight":-0.0127},{"period":"1month","weight":-0.0049},{"period":"3month","weight":0.017},{"period":"6month","weight":0.1184},{"period":"1year","weight":0.243},{"period":"ytd","weight":0.0244}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"哈尔滨誉衡药业股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"103000人(较上一季度增加5.86%)","perCapita":"20380股","listingDate":"2010-06-23","address":"黑龙江省哈尔滨市呼兰区利民经济技术开发区北京路29号","registeredCapital":"223202万元","survey":" 哈尔滨誉衡药业股份有限公司的主营业务是药品的研发、生产和销售。公司的主要产品是鹿瓜多肽注射液、安脑丸、安脑片、氯化钾缓释片、注射用磷酸肌酸钠、银杏达莫注射液、注射用多种维生素(12)、注射用氟尿嘧啶、注射用盐酸平阳霉素。公司核心产品市场认可度高,鹿瓜多肽注射液曾被黑龙江省医药行业协会评为“医药行业科技进步奖一等奖”、氯化钾缓释片曾被评为广东省名优高新技术产品、银杏达莫注射液曾被评为山西省名牌产品。","listedPrice":50},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"誉衡药业(002437)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供誉衡药业(002437)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"誉衡药业,002437,誉衡药业股票,誉衡药业股票老虎,誉衡药业股票老虎国际,誉衡药业行情,誉衡药业股票行情,誉衡药业股价,誉衡药业股市,誉衡药业股票价格,誉衡药业股票交易,誉衡药业股票购买,誉衡药业股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"誉衡药业(002437)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供誉衡药业(002437)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}